Online Adverse Event Monitoring Could Guide Ph IV Spending say Researchers
Researchers behind a new automated adverse drug event monitoring method say it could act as an early warning system and guide Phase IV trials.
Archives for June 23, 2013
Updated
WIL Expands EU Capacity with Acquisition of Ricerca’s French Research Facility
CRO WIL Research has doubled its capacity in the EU with the acquisition of Ricerca Biosciences’ Lyon, France facility.
Bayer Clinical Units to be Transferred to Outsourcing Partner CRS
Pharma companies may be moving away from global CROs and towards more specialised early phase partners, according to German firm CRS who has inked a partnership deal with Bayer.
Irish Manufacturing Still Firm for Pfizer as Viagra Loses UK Patent
Pfizer says it remains committed to manufacturing in Ireland following the patent expiry of Viagra in UK last week.
TKL Research Builds New Phase I Research Facility in NJ
CRO TKL Research is constructing a new clinical research facility that will include a 30-bed, Phase I unit as well as multiple, outpatient clinical examination rooms.
India’s Roselabs Invests $67M in New Pre-Filled Syringe Facility
Roselabs Bioscience has invested $67M into a pre-filled syringe facility in India and is exploring the option of exporting the products to 35 countries in unregulated markets in southeast Asia, Latin America and Africa.